Cadrenal Therapeutics (CVKD) Appoints Jeff Cole as Chief Operating Officer in Advance of Tecarfarin Phase 3 Pivotal Trial streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
PONTE VEDRA, Fla., Feb. 8, 2024 /PRNewswire/ Cadrenal Therapeutics, Inc. , a biopharmaceutical company developing tecarfarin, a novel Vitamin K Antagonist for unmet needs in anticoagulation .
Cognition Therapeutics, Inc. announced that Quang Pham Joins Cognition as a Board Director, Bringing Vision and - Expertise to Fuel Company s Growth Cognition, a connected ad platform, announced the.
The 26th BioFlorida Annual Conference united 500+ statewide leaders from Florida's life sciences industry, representing biopharmaceutical, medical technology, digital health, and health systems, globally recognized research universities and research institutions, investors, policymakers, and economic development agencies, to spotlight the momentum and success in science, business, and public policy and spur collaboration and future global growth for Florida's companies.